MWN109 4: Clinical Trials

3 trials of MWN109 4, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Phase 11Completed 1

Follow MWN109 4: new trials by email Literature Review of MWN109 4 trials Research Report on MWN109 4

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus
MWN109 1, MWN109 2, MWN109 3 - Type 2 Diabetes Mellitus (T2DM)
Phase 2RecruitingShanghai Minwei Biotechnology Co., Ltd2402026-06-232026-09-09
Phase 2 Study of MWN109 Tablet in Participants With Overweight or Obesity
MWN109 1, MWN109 2, MWN109 3 - Overweight , Obesity
Phase 2CompletedShanghai Minwei Biotechnology Co., Ltd2552026-01-052026-08-28
Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or Obesity
MWN109 1, MWN109 2, MWN109 3 - Overweight , Obesity
Phase 1CompletedShanghai Minwei Biotechnology Co., Ltd402025-07-142026-10-28

Conditions studied

Obesity (2)  ·  Overweight (2)  ·  Diabetes Mellitus, Type 2 (1)

Sponsors

Shanghai Minwei Biotechnology Co., Ltd (3)

Countries

China (3)